AIMS: The present study evaluated a comparative and combined hepatoprotective effect of atorvastatin (AS) and ferulic acid (F) against high fat diet (HFD) induced oxidative stress in terms of hyperlipidemia, anti-oxidative status, lipid peroxidation and inflammation. MAIN METHODS: Male Swiss albino mice were given a diet containing high fat (H) (23.9% wt/wt), supplemented with AS (10mg/kg) or F (100mg/kg) and both (10 and 100mg/kg) for 8weeks. The control mice (C) were fed with normal diet. KEY FINDINGS: The H mice exhibited increased body weight; hyperlipidemia; serum level of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6); hepatic lipid profile; lipid accumulation; reactive oxygen species (ROS) of hepatocytes, lipid peroxidation and liver antioxidant capacity was decreased. Immunofluorescent and Western blot assay revealed activation of nuclear factor kappa B (NF-κB) signaling pathway. The addition of F or AS and both in the diet significantly counteracted HFD induced body weight gain; hyperlipidemia; TNF-α, IL-6; hepatic lipid profile; fatty infiltration; NF-κB signaling pathway; ROS; lipid peroxidation and moreover elevated levels of hepatic antioxidant enzymes activity were observed. SIGNIFICANCE: Simultaneous treatment with AS, F and their combination protected against HFD induced weight gain and oxidative stress. The protection may be attributed to the hypolipidemic and free radical scavenging activity of AS or F and their combination. This study illustrates that AS and F have relatively similar hypolipidemic, antioxidative, anti-inflammatory actions and the AS+F combination along with HFD has shown outstanding effects as compared to other treated groups.
AIMS: The present study evaluated a comparative and combined hepatoprotective effect of atorvastatin (AS) and ferulic acid (F) against high fat diet (HFD) induced oxidative stress in terms of hyperlipidemia, anti-oxidative status, lipid peroxidation and inflammation. MAIN METHODS: Male Swiss albino mice were given a diet containing high fat (H) (23.9% wt/wt), supplemented with AS (10mg/kg) or F (100mg/kg) and both (10 and 100mg/kg) for 8weeks. The control mice (C) were fed with normal diet. KEY FINDINGS: The H mice exhibited increased body weight; hyperlipidemia; serum level of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6); hepatic lipid profile; lipid accumulation; reactive oxygen species (ROS) of hepatocytes, lipid peroxidation and liver antioxidant capacity was decreased. Immunofluorescent and Western blot assay revealed activation of nuclear factor kappa B (NF-κB) signaling pathway. The addition of F or AS and both in the diet significantly counteracted HFD induced body weight gain; hyperlipidemia; TNF-α, IL-6; hepatic lipid profile; fatty infiltration; NF-κB signaling pathway; ROS; lipid peroxidation and moreover elevated levels of hepatic antioxidant enzymes activity were observed. SIGNIFICANCE: Simultaneous treatment with AS, F and their combination protected against HFD induced weight gain and oxidative stress. The protection may be attributed to the hypolipidemic and free radical scavenging activity of AS or F and their combination. This study illustrates that AS and F have relatively similar hypolipidemic, antioxidative, anti-inflammatory actions and the AS+F combination along with HFD has shown outstanding effects as compared to other treated groups.
Authors: Maria Luisa Justo; Carmen Claro; Maximilian Zeyda; Thomas M Stulnig; María Dolores Herrera; Rosalía Rodríguez-Rodríguez Journal: Eur J Nutr Date: 2015-08-13 Impact factor: 5.614
Authors: Yang Nana; Jiao Peng; Zhang Jianlin; Zhang Xiangjian; Yao Shutong; Zhan Enxin; Li Bin; Zong Chuanlong; Tian Hua; Si Yanhong; Du Yunsai; Qin Shucun; Wang Hui Journal: PLoS One Date: 2015-09-23 Impact factor: 3.240
Authors: Alessandro Leone; Giovanni Fiorillo; Franca Criscuoli; Stefano Ravasenghi; Laura Santagostini; Gelsomina Fico; Angela Spadafranca; Alberto Battezzati; Alberto Schiraldi; Federica Pozzi; Sara di Lello; Sandro Filippini; Simona Bertoli Journal: Int J Mol Sci Date: 2015-08-12 Impact factor: 5.923
Authors: T S de Melo; P R Lima; K M M B Carvalho; T M Fontenele; F R N Solon; A R Tomé; T L G de Lemos; S G da Cruz Fonseca; F A Santos; V S Rao; M G R de Queiroz Journal: Braz J Med Biol Res Date: 2017-01-05 Impact factor: 2.590
Authors: B M Bocco; G W Fernandes; F B Lorena; R M Cysneiros; M A Christoffolete; S S Grecco; C L Lancellotti; P Romoff; J H G Lago; A C Bianco; M O Ribeiro Journal: Braz J Med Biol Res Date: 2016-02-02 Impact factor: 2.590